We are a registered 501C that helps raise awareness and money to fight and fund research for pediatric cancer and help families on the Delmarva Peninsula
As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.